Cargando…
Perspective of Future Potent Therapies for Fuchs Endothelial Corneal Dystrophy
BACKGROUND: Fuchs Endothelial Corneal Dystrophy (FECD) is a progressive disease that affects the corneal endothelium in both eyes. Recent studies have identified a novel genetic basis for FECD, and basic research findings have provided evidence for its underlying pathophysiology. Since its first des...
Autores principales: | Okumura, Naoki, Hayashi, Ryousuke, Koizumi, Noriko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062905/ https://www.ncbi.nlm.nih.gov/pubmed/30123380 http://dx.doi.org/10.2174/1874364101812010154 |
Ejemplares similares
-
Evaluating Keratoplasty for Fuchs’ Endothelial Corneal Dystrophy: A Literature Review
por: Hemaya, Maria, et al.
Publicado: (2023) -
Fuchs endothelial corneal dystrophy: current perspectives
por: Vedana, Gustavo, et al.
Publicado: (2016) -
RNA-Seq–based transcriptome analysis of corneal endothelial cells derived from patients with Fuchs endothelial corneal dystrophy
por: Nakagawa, Tatsuya, et al.
Publicado: (2023) -
Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model
por: Okumura, Naoki, et al.
Publicado: (2018) -
Shotgun proteomics identification of proteins expressed in the Descemet’s membrane of patients with Fuchs endothelial corneal dystrophy
por: Nakagawa, Tatsuya, et al.
Publicado: (2023)